Other languages Uni-Bio Science Group Limited

Equities

690 KYG9198H1406

Market Closed - Hong Kong S.E. Other stock markets 04:08:42 2024-06-28 EDT			5-day change	1st Jan Change
0.065 ^HKD	0.00%		-2.99%	-9.72%

03-27	Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-14	Uni-Bio Science's Profit to Climb in 2023	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-27
Uni-Bio Science's Profit to Climb in 2023	02-14
Uni-Bio Science Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023	02-13
Chinese Regulator NMPA Accepts Uni-Bio's Marketing Application for Eye Drops	01-23
Uni-Bio Science Group Limited Announces the Acceptance of its Marketing Application for Diquafosol Sodium Eye Drops by the China National Medical Products Administration	01-23
China Grants Uni-Bio Science's Injection for Orthopedic Diseases	01-22
Uni-Bio Science Group Limited Announces Approval of Marketing Application of Bogutai (Teriparatide Injection) by the China National Medical Products Administration	01-21
Uni-Bio Science Group Limited commences an Equity Buyback for 636,476,815 shares, representing 10% of its issued share capital, under the authorization approved on May 19, 2023.	12-13
Uni-Bio Science Group Limited Announces the Resignation of Ms. Zhang Yanfen as Executive Director	11-15
Uni-Bio Science's Unit Grants 7.2 Million Yuan Loan to Taili Biomedical Technology	23-09-18
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28
Uni-Bio Science Group Limited Appoints Zhang Yanfen as an Executive Director	23-08-11
Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27
Uni-Bio Science Group Limited Provides Financial Guidance for the Year Ended 31 December 2022	23-03-06
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29
Uni-Bio Science Group Limited Announces Marketing Application of Bogutai (Teriparatide Injection) Officially Accepted by the China National Medical Products Administration	22-06-28
Uni-Bio Science Group Limited Announces Executive Changes	22-03-31
Uni-Bio Science Narrows Loss on Higher Core Drugs Sales in 2021; Shares Rise 3%	22-03-22
Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-21
Uni-Bio Science Arm Signs R&D Deal for Medical Aesthetics Materials Development	22-01-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Uni-Bio Science Group Limited

Equities

690

KYG9198H1406

Other languages

Filters